1)adipogenic differentiation脂向分化
1.The differential expression of miRNA-134 during adipogenic differentiation of ADSCs脂肪基质细胞脂向分化过程中MicroRNA-134的表达变化
2.Objective:To explore the differential expression of microRNA-16 during adipogenic differentiation of adipose derived stromalcells(ADSCs).目的:了解脂肪基质细胞(ADSCs)在脂向分化过程中MicroRNA-21(miRNA-21)表达变化情况。
英文短句/例句
1.Changes in MicroRNA-21 Expression during Adipogenic Differentiation Of Adipose Tissue-derived Stromal Cells脂肪基质细胞脂向分化过程中MicroRNA-21的表达变化
2.The differential expression of miRNA-134 during adipogenic differentiation of ADSCs脂肪基质细胞脂向分化过程中MicroRNA-134的表达变化
3.An Experimental Study of miRNA-27b Expression during Adipogenic Differentiation by Adipose-Derived Stem Cells脂肪干细胞脂向分化过程中miRNA-27b表达的研究
4.Changes in microRNA-16 expression during adipogenic differentiation of adipose tissue-derived stromal cellsmicroRNA-16在脂肪基质细胞脂向分化过程中的表达变化
5.The Effect of Psoralen on Proliferation Capacity, Differentiation to Adipocyte of Marrow Stromal Cells from Rats;补骨脂素对大鼠骨髓间充质干细胞增殖和脂向分化的影响
6.Expression of miRNA-22 during adipogenic differentiation process of adipose tissue-derived stromal cells in vitromiRNA-22在脂肪基质细胞体外脂向分化过程中的表达
7.Effects of Metformin on Mesenchymal Stem Cells cultured in Adipogenic Medium二甲双胍对脂向分化间充质干细胞的影响
8.Differentiation of human adipose-derived stem cells into adipocytes人脂肪干细胞向脂肪细胞的定向分化
9.microRNA-27b Negatively Regulate Adipocyte Differentiation Through Targeting PPARγmiR-27b通过靶向于PPARγ触发脂肪细胞分化
10.Induction of Differentiation of Adipose Tissue-derived Stem Cells into Neurons脂肪干细胞向神经元诱导分化的研究
11.Molecular Mechanism of the Differentiation from Mouse Embryonic Stem Cells into Adipocytes小鼠胚胎干细胞向脂肪细胞分化的分子机制
12.Human adipose tissue-derived stromal cells differentiate into osteogenic cells来源于脂肪组织的基质细胞向成骨细胞分化
13.The Proliferation and Differentiation of Adipose-derived Stem Cell into Cardiomyocyte脂肪干细胞增殖特性及向心肌细胞分化的研究
14.Characteristics of Human adipose tissue-derived stem cells and the ability of differentiate into endothelial cells in vitro体外诱导人脂肪干细胞向内皮细胞分化的研究
15.Experimental Study on Induced Differentiation of Rat Hair Follicle Bulge Cells into Sebocytes in Intro;体外诱导毛囊Bulge细胞向皮脂腺细胞定向分化的研究
16.A Comparison between BMSCs and ADSCs on Inducing into Neuron-like Cells in Vitro骨髓源及脂肪源干细胞向神经元样细胞方向分化的比较实验研究
17.The Interaction between Activated Lymphocytes and Adipogenic Differentiation of BMMSCs and Its Significance淋巴细胞活化与BMMSCs向脂肪分化的相互影响及可能的临床意义
18.Differentiation of Rat ADSCs into Chondrocytes Transfected by SOX-9 and TGF-β1 Gene Alone and TogetherSOX-9和转化生长因子-β1共同诱导大鼠脂肪干细胞向软骨细胞分化
相关短句/例句
adipocytic trans-differentiation成脂横向分化
1.OBJECTIVE To study the effects of 17 β-estradiol on the osteogenic and adipogenic differentiation of primary mouse bone marrow stromal cells(MSCs)and the adipocytic trans-differentiation of primary mouse osteoblasts(OBs).目的研究17β-雌二醇对小鼠原代骨髓基质细胞成骨、成脂分化以及小鼠原代成骨细胞成脂横向分化的影响。
3)adipogenic differentiation成脂分化
1.Effects of Alendronate sodium on osteogenic and adipogenic differentiation of bone marrow stromal cells;阿伦磷酸钠对小鼠骨髓基质细胞成骨和成脂分化的影响
2.Effects of RNAi for target on PPARγ to suppress adipogenic differentiation of MSCs of rabbit induced by ethanol靶向PPARγ基因RNA干扰对乙醇诱导家兔骨髓基质细胞成脂分化的影响
3.Effects of RNAi for target on PPARγ to suppress adipogenic differentiation of MSCs of rabbit induced by steroid靶向PPARγ RNA干扰对激素诱导家兔骨髓基质细胞成脂分化的影响
4)adipocytic differentiation成脂分化
1.Objective To investigate the effect of ghrelin on adipocytic differentiation of bone marrow stromal cells (BMSCs).目的观察胃促生长素ghrelin对原代培养小鼠骨髓基质细胞成脂分化的影响。
5)adipogenesis differentiation成脂分化
1.The purpose of the experiment is to investigate the function of ATRA on the proliferation and adipogenesis differentiation of porcine adipose mesenchymal stem cells(AMSCs).利用MTT比色检测不同浓度的全反式维甲酸(alltransretinoic acid,ATRA)对猪AMSCs增殖的影响;光学显微镜下观察猪AMSCs向脂肪细胞分化的形态学变化;油红O染色提取法分析不同浓度ATRA对猪AMSCs成脂分化的影响;RT-PCR检测脂肪细胞分化标志基因LPL和aP2mRNA的变化。
6)Adipogenesis[,?dip?u'd?enisis]成脂分化
延伸阅读
普鲁脂芬 ,苯酰降脂丙酯 ,立平脂药物名称：力平脂英文名：Lipanthgl别名： 力平脂；美利普特 ,非诺贝特,苯酸降脂丙酯;降脂异丙酯;普鲁脂芬 ,苯酰降脂丙酯 ,立平脂外文名：Fenofibrate, Lipanthyl药理作用：本品有显著降低血清甘油三酯和极低密度脂蛋白、胆固醇、低密度脂蛋白和载脂蛋白-B的浓度，并使高密脂蛋白、载脂蛋白-A1及载脂蛋白-A与载脂蛋白-B的比值升高，较氯贝丁酯作用为强。 体内过程： 口服后胃肠道吸收快，4-6小时达峰值，肝内代谢，24小时内大部分以代谢物、少量以原形随尿及粪便排出，半衰期约为22-26小时。 成分： 非诺贝特 适应症： 成人饮食控制疗法不理想的高胆固醇血症和／或高甘油三酯血症。 用量用法：⑴ 微粒化胶囊：200mg qd,进餐时服用。标准化胶囊：100 mg tid或300 mg qd。维持剂量为100 mg bid或微粒化胶囊 200mg ,qd。 ⑵口服：每日３００ｍｇ，可早餐后１００ｍｇ，晚餐后２００ｍｇ，或晚餐后３００ｍｇ顿服。一般服药１０日左右有明显疗效，２周左右（严重者４周左右）血脂恢复正常水平。此后，在饮食及运动配合下，维持量为每日１００～２００ｍｇ。儿童每公斤５ｍｇ。 禁忌： 有肝或肾功能损害者，儿童及妊娠妇女。 不良反应： 胃肠不适，如消化不良；皮肤过敏反应；一过性转氨酶水平升高及肌肉疼痛（偶尔伴肌酶水平增高）。 注意事项： 本药不能作为饮食控制的替代疗法；需定期进行常规血液及肝功能检查。 (注意事项 1.本品毒性甚低，少数病人可见肝功能障碍、停药后２～４周恢复正常。 2.曾有血尿素氮增高。 3.偶有口干、食欲不振、大便次数增多、皮疹、腹胀和白细胞减少等。 4.孕妇禁用；肝、肾功能不全者慎用。 )药物相互作用： 慎与其它降胆固醇药（其它贝特类，他汀类）同服。服用抗凝剂时慎用本药。 规格： 胶囊 标准化力平脂 100 mg x 25粒。300mg x 10粒。胶囊 微粒化力平脂 200 mg x 10粒。 类别：调节血脂及抗动脉硬化药
